Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion

Not yet recruitingOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2027

Conditions
Microvascular DiseaseMicrovascular ComplicationsDiabetes Mellitus Type 2Cerebral HypoperfusionDementia
Interventions
DIAGNOSTIC_TEST

PET

PET imaging will be performed with a Discovery 710 PET/CT scanner (GE Healthcare, Milwaukee, WI, USA). Two 5-minute PET recordings will be performed of each subject within a single scanning session of 70 min. One 5-minute scan is conducted of the brain in rest. \[15O\]H2O, is produced on-site (GENtrace, GE, Uppsala, Sweden), and 600 MBq \[15O\]H2O is intravenously injected by an automatic Hidex Radiowater Generator (Hidex, Turku, Finland). To induce brain vasodilation, 1 g of acetazolamide is infused over 5 min and 15 min later the brain is scanned. Cerebral perfusion is calculated using PMOD software (PMOD Technologies, Switzerland).

Trial Locations (1)

2400

Bispebjerg and Frederiksberg Hospital, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Danish Cardiovascular Academy

UNKNOWN

collaborator

Bispebjerg Hospital

OTHER

collaborator

The Dagmar Marshall Foundation

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

University Hospital Bispebjerg and Frederiksberg

OTHER